{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:43Z","timestamp":1792831063889,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioorg.2026.110602","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:31:11Z","timestamp":1790836271000},"page":"110602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and anticancer potential of new peptide conjugates via urokinase inhibition: biological and in silico studies"],"prefix":"10.1016","volume":"183","author":[{"given":"Taghreed Abdelstar","family":"Sheha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany S.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahenda M.","family":"El-Messery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan M.","family":"Eisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2026.110602_bb0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3892\/ijo.2020.5099","article-title":"Anticancer peptide: physicochemical property, functional aspect and trend in clinical application","volume":"57","author":"Chiangjong","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2026.110602_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103332","article-title":"Towards breast cancer targeting: synthesis of tetrahydroindolocarbazoles, antibreast cancer evaluation, uPA inhibition, molecular genetic and molecular modelling studies","volume":"93","author":"Ahmed","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110602_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110194","article-title":"Anticancer peptides mechanisms, simple and complex","volume":"368","author":"Norouzi","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110602_bb0020","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.biocel.2006.10.008","article-title":"Urokinase-type plasminogen activator","volume":"39","author":"Crippa","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110602_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.818616","article-title":"Modulation of cellular function by the urokinase receptor signalling: a mechanistic view","volume":"10","author":"Alfano","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110602_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12061167","article-title":"Urokinase-type plasminogen activator receptor (uPAR) in inflammation and disease: a unique inflammatory pathway activator","volume":"12","author":"Hamada","year":"2024","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110602_bb0035","first-page":"C721","article-title":"Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation","volume":"321","author":"Gonias","year":"2021","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110602_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030498","article-title":"Therapeutic strategies targeting urokinase and its receptor in cancer","volume":"14","author":"Masucci","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110602_bb0045","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.jid.2018.04.024","article-title":"Enhancement of cutaneous wound healing by Dsg2 augmentation of uPAR secretion","volume":"138","author":"Cooper","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12967-022-03329-3","article-title":"Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer","volume":"20","author":"Zhai","year":"2022","journal-title":"J. Transl. Med."},{"issue":"6\u20137","key":"10.1016\/j.bioorg.2026.110602_bb0055","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.biocel.2008.01.020","article-title":"Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization","volume":"40","author":"Owen","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0060","article-title":"Cancer treatment using peptides: current therapies and future prospects","volume":"2012","author":"Thundimadathil","year":"2012","journal-title":"J. Amino Acids"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6769-6-1","article-title":"Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator","volume":"6","author":"Heynekamp","year":"2006","journal-title":"BMC Chem. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110602_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/jmbi.2000.3966","article-title":"Crystals of the urokinase type plasminogen activator variant \u03b2c-uPA in complex with small molecule inhibitors open the way towards structure-based drug design","volume":"301","author":"Zeslawska","year":"2000","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110602_bb0075","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/ijc.26156","article-title":"Anti-tumour\/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty?","volume":"129","author":"Matthews","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2026.110602_bb0080","doi-asserted-by":"crossref","first-page":"116116","DOI":"10.1016\/j.bmc.2021.116116","article-title":"Systematic evaluation of structure\u2013property relationships and pharmacokinetics in 6-(hetero) aryl-substituted matched pair analogs of amiloride and 5-(N, N-hexamethylene) amiloride","volume":"37","author":"Buckley","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4014\/jmb.1907.07003","article-title":"A review on structure, modifications and structure-activity relation of quercetin and its derivatives","volume":"30","author":"Magar","year":"2019","journal-title":"J. Microbiol. Biotechnol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110602_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/catal14110787","article-title":"Advancements in serine protease inhibitors: from mechanistic insights to clinical applications","volume":"14","author":"Wei","year":"2024","journal-title":"Catalysts"},{"issue":"15","key":"10.1016\/j.bioorg.2026.110602_bb0095","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.bmcl.2015.05.020","article-title":"Synthesis, molecular docking and anticancer studies of peptides and iso-peptides","volume":"25","author":"Jabeen","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110602_bb0100","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1055\/s-0030-1260159","article-title":"Tri-, tetra-and pentapeptidoylbenzotriazoles: novel synthetic intermediates","volume":"2011","author":"Abdelmajeid","year":"2011","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2026.110602_bb0105","doi-asserted-by":"crossref","unstructured":"El-Nachef, C., Bajaj, K., Koblick, J., & Katritzky, A. R. (2012). Microwave-assisted formation of peptide\u2013vitamin conjugates. Eur. J. Org. Chem., 2012(23), 4412\u20134419.","DOI":"10.1002\/ejoc.201200323"},{"key":"10.1016\/j.bioorg.2026.110602_bb0110","series-title":"Peptides as Drugs: Discovery and Development","year":"2009"},{"issue":"47","key":"10.1016\/j.bioorg.2026.110602_bb0115","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1016\/j.tetlet.2010.09.075","article-title":"An efficient one-pot access to trithiocarbonate-tethered peptidomimetics","volume":"51","author":"Narendra","year":"2010","journal-title":"Tetrahedron Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110602_bb0120","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0196-9781(01)00537-X","article-title":"Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability","volume":"22","author":"Witt","year":"2001","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1039\/C1MD00177A","article-title":"Synthesis of chiral \u03b1-amino acid-derived 1H-1,2,4-triazoles and 1,2,4-triazines","volume":"3","author":"Ghazvini Zadeh","year":"2012","journal-title":"MedChemComm"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110602_bb0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4155\/fmc.09.23","article-title":"Manufacturing peptides as active pharmaceutical ingredients","volume":"1","author":"Zompra","year":"2009","journal-title":"Future Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110602_bb0135","first-page":"251","article-title":"Synthesis of some anticancer agent conjugated to aminoacids through amide bond with expected biological activity","volume":"7","author":"Abdulridha","year":"2015","journal-title":"Pharma. Chem."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2026.110602_bb0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0014-5793(02)03311-2","article-title":"High-affinity urokinase-derived cyclic peptides inhibiting urokinase\/urokinase receptor-interaction: effects on tumor growth and spread","volume":"528","author":"Sato","year":"2002","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43934-w","article-title":"Targeted imaging of uPAR expression in vivo with cyclic AE105 variants","volume":"13","author":"Leth","year":"2023","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110602_bb0150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7150\/thno.5557","article-title":"Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy","volume":"3","author":"Li","year":"2013","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110602_bb0155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0960-894X(01)00815-0","article-title":"4-amidinobenzylamine-based inhibitors of urokinase","volume":"12","author":"K\u00fcnzel","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"32","key":"10.1016\/j.bioorg.2026.110602_bb0160","doi-asserted-by":"crossref","first-page":"33613","DOI":"10.1074\/jbc.M314151200","article-title":"Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents","volume":"279","author":"Schweinitz","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110602_bb0165","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0960-894X(00)00149-9","article-title":"Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors","volume":"10","author":"Tamura","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110602_bb0170","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1021\/jm060622g","article-title":"Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: optimization of the P4 position","volume":"49","author":"Joossens","year":"2006","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110602_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122686","article-title":"Role of anti-cancer peptides as immunomodulatory agents: potential and design strategy","volume":"14","author":"Tripathi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110602_bb0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/tcrm.2007.3.2.341","article-title":"Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)","volume":"3","author":"Le Tourneau","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110602_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126172","article-title":"Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes","volume":"10","author":"Yousif","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.110602_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.peptides.2017.12.016","article-title":"D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo","volume":"101","author":"Furlan","year":"2018","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110602_bb0195","first-page":"5517","article-title":"Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors","volume":"43","author":"Markus","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110602_bb0200","series-title":"Bioactive carboxylic compound classes: Pharmaceuticals and Agrochemicals","first-page":"1","article-title":"Different roles of carboxylic functions in pharmaceuticals and agrochemicals","author":"Lamberth","year":"2016"},{"key":"10.1016\/j.bioorg.2026.110602_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.127809","article-title":"Exploration of biological potency of carboxylic acid derivatives: designing, synthesis, characterizations and molecular docking study","volume":"1207","author":"Sirajuddin","year":"2020","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0215","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1038\/s41598-025-93451-1","article-title":"Synthesis and antitumor evaluation of amino acid conjugates of monocarbonyl curcumin in hepatocellular carcinoma cell","volume":"15","author":"Cao","year":"2025","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110602_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27217631","article-title":"Amino-acid-conjugated natural compounds: aims, designs and results","volume":"27","author":"Arifian","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110602_bb0225","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.addr.2012.10.001","article-title":"Amino acids as promoieties in prodrug design and development","volume":"65","author":"Vig","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110602_bb0230","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.13005\/bpj\/2296","article-title":"Preparation, diagnosis and evaluation of cyclic-tryptophan derivatives as anti breast cancer agents","volume":"14","author":"Aljamali","year":"2021","journal-title":"Biomed. Pharmacol. J."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110602_bb0235","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/ijms18030544","article-title":"D-Amino acid position influences the anticancer activity of galaxamide analogs: an apoptotic mechanism study","volume":"18","author":"Bai","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110602_bb0240","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.3390\/molecules29194770","article-title":"Indole derivatives: a versatile scaffold in modern drug discovery\u2014an updated review on their multifaceted therapeutic applications (2020\u20132024)","volume":"29","author":"Mo","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s43094-020-00141-y","article-title":"A brief review of the biological potential of indole derivatives","volume":"6","author":"Kumar","year":"2020","journal-title":"Future J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110602_bb0250","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.2174\/1389557522666220330123538","article-title":"Recent progress of bioactivities, mechanisms of action, total synthesis, structural modifications and structure-activity relationships of indole derivatives: a review","volume":"22","author":"Li","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1573406410666140507094954","article-title":"N-valproyl-L-phenylalanine as new potential antiepileptic drug: synthesis, characterization and in vitro studies on stability, toxicity and anticonvulsant efficacy","volume":"11","author":"De Caro","year":"2015","journal-title":"Med. Chem."},{"issue":"34","key":"10.1016\/j.bioorg.2026.110602_bb0260","doi-asserted-by":"crossref","first-page":"23701","DOI":"10.1074\/jbc.M114.576272","article-title":"A WXW motif is required for the anticancer activity of the TAT-RasGAP317\u2013326 peptide","volume":"289","author":"Barras","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110602_bb0265","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1573406415666190416121448","article-title":"Hybrids of coumarin derivatives as potent and multifunctional bioactive agents: a review","volume":"16","author":"Fotopoulos","year":"2020","journal-title":"Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110602_bb0270","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ddr.21728","article-title":"Amino acid conjugates of 2-mercaptobenzimidazole provide better anti-inflammatory pharmacology and improved toxicity profile","volume":"81","author":"Khan","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.110602_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111909","article-title":"Recent advances in steroid amino acid conjugates: old scaffolds with new dimensions","volume":"187","author":"Singla","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110602_bb0280","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/mp900084v","article-title":"Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers","volume":"6","author":"Gupta","year":"2009","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110602_bb0285","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/jhet.5570350511","article-title":"Applications of benzotriazole methodology in heterocycle ring synthesis and substituent introduction and modification","volume":"35","author":"Katritzky","year":"1998","journal-title":"J. Heterocyclic Chem."},{"issue":"16\u201317","key":"10.1016\/j.bioorg.2026.110602_bb0290","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/S0040-4020(01)87080-0","article-title":"Benzotriazole: a novel synthetic auxiliary","volume":"47","author":"Katritzky","year":"1991","journal-title":"Tetrahedron"},{"issue":"48","key":"10.1016\/j.bioorg.2026.110602_bb0295","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1021\/ja00153a032","article-title":"General and efficient carbon insertion route to one-carbon-homologated. alpha.-aryl,. alpha.-alkenyl,. alpha.-alkoxy, and. alpha.-phenylthio alkyl ketones","volume":"117","author":"Katritzky","year":"1995","journal-title":"J. Am. Chem. Soc."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110602_bb0300","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.1021\/jo960841h","article-title":"General and efficient insertions of carbons carrying aryl and heteroaryl groups: synthesis of \u03b1-aryl-and \u03b1-heteroaryl-substituted ketones","volume":"61","author":"Katritzky","year":"1996","journal-title":"J. Org. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110602_bb0305","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5562\/cca2124","article-title":"Benzotriazole as a synthetic auxiliary","volume":"85","author":"Zorc","year":"2012","journal-title":"Croat. Chem. Acta"},{"key":"10.1016\/j.bioorg.2026.110602_bb0310","series-title":"The Chemistry of Benzotriazole Derivatives","year":"2016"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110602_bb0315","first-page":"43","article-title":"Aminoacyl benzotriazolides: versatile reagents for the preparation of peptides and their mimetics and conjugates","volume":"46","author":"Panda","year":"2013","journal-title":"Aldrichimica Acta"},{"key":"10.1016\/j.bioorg.2026.110602_ce.other-ref_tnn_h1q_tkc","doi-asserted-by":"crossref","unstructured":"(a)Han, S. Y., & Kim, Y. A. (2005). 110 Tetrahedron, 2004, 60, 2447\u20132467.","DOI":"10.1016\/j.tet.2004.01.020"},{"key":"10.1016\/j.bioorg.2026.110602_or0015","doi-asserted-by":"crossref","unstructured":"(b)CAGN Montalbetti and V. Falque. Tetrahedron, 61, 10827\u201310852.","DOI":"10.1016\/j.tet.2005.08.031"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110602_bb0325","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1016\/S0040-4020(99)00344-0","article-title":"The diisopropylcarbodiimide\/1-hydroxy-7-azabenzotriazole system: segment coupling and stepwise peptide assembly","volume":"55","author":"Carpino","year":"1999","journal-title":"Tetrahedron"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110602_bb0330","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1021\/jo00116a054","article-title":"Efficiency in peptide coupling: 1-hydroxy-7-azabenzotriazole vs 3, 4-dihydro-3-hydroxy-4-oxo-1, 2, 3-benzotriazine","volume":"60","author":"Carpino","year":"1995","journal-title":"J. Org. Chem."},{"issue":"26","key":"10.1016\/j.bioorg.2026.110602_bb0335","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/jo980807y","article-title":"Use of onium salt-based coupling reagents in peptide Synthesis1","volume":"63","author":"Albericio","year":"1998","journal-title":"J. Org. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110602_bb0340","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/ol016063j","article-title":"The 5, 6-and 4, 5-benzo derivatives of 1-hydroxy-7-azabenzotriazole","volume":"3","author":"Carpino","year":"2001","journal-title":"Org. Lett."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110602_bb0345","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/S0040-4039(99)00245-2","article-title":"A selective method for the preparation of primary amides: synthesis of Fmoc-l-4-carboxamidophenylalanine and other compounds","volume":"40","author":"Wang","year":"1999","journal-title":"Tetrahedron Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110602_bb0350","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0040-4039(99)00089-1","article-title":"Addition of HOAt dramatically improves the effectiveness of pentafluorophenyl-based coupling reagents","volume":"40","author":"Klose","year":"1999","journal-title":"Tetrahedron Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110602_bb0355","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0040-4039(00)94371-5","article-title":"PyBOP\u00ae: a new peptide coupling reagent devoid of toxic by-product","volume":"31","author":"Coste","year":"1990","journal-title":"Tetrahedron Lett."},{"issue":"07","key":"10.1016\/j.bioorg.2026.110602_bb0360","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/s-1984-30895","article-title":"O-Benzotriazolyl-N, N, N\u2032, N\u2032-tetramethyluronium hexafluorophosphate as coupling reagent for the synthesis of peptides of biological interest","volume":"1984","author":"Dourtoglou","year":"1984","journal-title":"Synthesis"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110602_bb0365","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1055\/s-2001-18098","article-title":"1-Hydroxy-7-azabenzotriazole (HOAt) and N-[(dimethylamino)-1H-1, 2, 3-triazolo-[4, 5-b] pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate N-oxide (HATU)","volume":"2001","author":"Kienh\u00f6fer","year":"2001","journal-title":"Synlett"},{"issue":"51","key":"10.1016\/j.bioorg.2026.110602_bb0370","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.1016\/S0040-4020(00)00963-7","article-title":"Highly efficient synthesis of sterically hindered peptides containing N-methylated amino acid residues using a novel 1H-benzimidazolium salt","volume":"56","author":"Li","year":"2000","journal-title":"Tetrahedron"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110602_bb0375","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1021\/ja01156a011","article-title":"Preparation of peptides using mixed carboxylic acid anhydrides","volume":"73","author":"Vaughan","year":"1951","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110602_bb0380","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1055\/s-0029-1217827","article-title":"Chiral acylation with N-(protected \u03b1-aminoacyl) benzotriazoles for advantageous syntheses of peptides and peptide conjugates","volume":"15","author":"Katritzky","year":"2009","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2026.110602_bb0385","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1055\/s-2003-42462","article-title":"Efficient conversion of carboxylic acids into N-acylbenzotriazoles","volume":"18","author":"Katritzky","year":"2003","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2026.110602_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102997","article-title":"EGFR inhibitors and apoptotic inducers: design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules","volume":"89","author":"Abou-Zied","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"03","key":"10.1016\/j.bioorg.2026.110602_bb0395","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2005-861782","article-title":"N-(Cbz-and Fmoc-\u03b1-aminoacyl) benzotriazoles: stable derivatives enabling peptide coupling of Tyr, Trp, Cys, Met, and Gln with free amino acids in aqueous media with complete retention of chirality","volume":"2005","author":"Katritzky","year":"2005","journal-title":"Synthesis"},{"issue":"14","key":"10.1016\/j.bioorg.2026.110602_bb0400","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1021\/jo034187z","article-title":"Regiospecific C-acylation of pyrroles and indoles using N-acylbenzotriazoles","volume":"68","author":"Katritzky","year":"2003","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.110602_bb0405","series-title":"1-(\u03b1-Boc-Aminoacyl) Benzotriazoles: Stable Chiral \u03b1-Aminoacylation Reagents","author":"Katritzky","year":"2002"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110602_bb0410","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1055\/s-2005-871551","article-title":"Acylbenzotriazoles as advantageous N-, C-, S-, and O-acylating agents","volume":"2005","author":"Katritzky","year":"2005","journal-title":"Synlett"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110602_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25112501","article-title":"An efficient greener approach for N-acylation of amines in water using benzotriazole chemistry","volume":"25","author":"Ibrahim","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110602_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114661","article-title":"New thiazole-based derivatives as EGFR\/HER2 and DHFR inhibitors: synthesis, molecular modeling simulations and anticancer activity","volume":"241","author":"Sabry","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110602_bb0425","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejmech.2012.08.034","article-title":"Synthesis, antitumor, cytotoxic and antioxidant evaluation of some new pyrazolotriazines attached to antipyrine moiety","volume":"56","author":"Metwally","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110602_bb0430","first-page":"60","article-title":"Synthesis, mass spectroscopic studies, cytotoxicity evaluation and quantitative structure activity relationship of novel isoindolin-1, 3-dione derivatives","volume":"21","author":"Hossan","year":"2014","journal-title":"Chem. Process Eng. Res"},{"key":"10.1016\/j.bioorg.2026.110602_bb0435","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bioorg.2016.05.006","article-title":"Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo [3, 4-b] pyridine derivatives as potential anticancer agents","volume":"67","author":"Eissa","year":"2016","journal-title":"Bioorg. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110602_bb0440","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1158\/1078-0432.CCR-06-3032","article-title":"Intraperitoneal injection of a hairpin RNA\u2013expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice","volume":"13","author":"Gondi","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-007-0365-5","article-title":"Anti-cancer therapies targeting the tumor stroma","volume":"57","author":"Hofmeister","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110602_bb0450","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ctrv.2007.06.003","article-title":"Targeting uPA\/uPAR in prostate cancer","volume":"33","author":"Li","year":"2007","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioorg.2026.110602_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104323","article-title":"DNA binding studies of novel diazatruxenones analogs as potential anticancer agents: synthesis, antitumor investigation, DNA binding, SAR and molecular modeling calculation","volume":"104","author":"El Sayed","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110602_bb0460","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1021\/np900157t","article-title":"Synthesis and structure\u2013activity relationship studies of cytotoxic anhydrovinblastine amide derivatives","volume":"72","author":"Shao","year":"2009","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110602_bb0465","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1747-0285.2009.00811.x","article-title":"Convenient synthesis of ibuprofen and naproxen aminoacyl, dipeptidoyl and ester derivatives","volume":"73","author":"Katritzky","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2026.110602_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103797","article-title":"Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity","volume":"99","author":"Ibrahim","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2026.110602_bb0475","doi-asserted-by":"crossref","first-page":"10617","DOI":"10.1021\/acs.jmedchem.9b00908","article-title":"Optimization strategy of novel peptide-based Michael acceptors for the treatment of human African trypanosomiasis","volume":"62","author":"Ettari","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110602_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117987","article-title":"Synthesis of \u03b1-fluorocinnamate derivatives as novel cathepsin S inhibitors with in vitro antiproliferative activity against pancreatic cancer cells","volume":"115","author":"Citarella","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110602_bb0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/med.10054","article-title":"Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer","volume":"24","author":"de Bock","year":"2004","journal-title":"Med. Res. Rev."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110602_bb0490","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1021\/jm0002634","article-title":"Flexible alignment of small molecules","volume":"44","author":"Labute","year":"2001","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110602_bb0495","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/08893110701337727","article-title":"Structural characteristics of antifolate dihydrofolate reductase enzyme interactions","volume":"12","author":"Cody","year":"2006","journal-title":"Crystallogr. Rev."},{"issue":"30","key":"10.1016\/j.bioorg.2026.110602_bb0500","doi-asserted-by":"crossref","first-page":"20079","DOI":"10.1074\/jbc.M109.018010","article-title":"Multiple conformers in active site of human dihydrofolate reductase F31R\/Q35E double mutant suggest structural basis for methotrexate resistance","volume":"284","author":"Volpato","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bioorg.2026.110602_bb0505","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/ja00467a001","article-title":"Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms","volume":"99","author":"Allinger","year":"1977","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110602_bb0510","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1080\/07391102.2020.1824814","article-title":"Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases","volume":"40","author":"Kumar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110602_bb0515","doi-asserted-by":"crossref","first-page":"11407","DOI":"10.1021\/acsomega.8b01524","article-title":"Molecular dynamics simulations of the interactions between glial cell line-derived neurotrophic factor family receptor GFR\u03b11 and small-molecule ligands","volume":"3","author":"Ivanova","year":"2018","journal-title":"ACS Omega"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:58:01Z","timestamp":1792828681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826011387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":104,"alternative-id":["S0045206826011387"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110602","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anticancer potential of new peptide conjugates via urokinase inhibition: biological and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110602"}}